https://smoothenedagonistagoni....st.com/measuring-use
RESULTS during the median follow-up of 55 months, median general success (OS) was 22 months. By multivariate analysis, high MLR 0.49 (hazard ratio [HR], 2.37; 95% confidence period [C.I.], 1.39-4.04), large LDH (HR, 1.73; 95% C.I., 1.03-2.9 in the first model, team 2 (hour, 2.74; 95% C.I.;oreover, MLR and composite MLR-LDH could potentially end up in an incremental improvement when you look at the prognostic value of these biomarkers, used as stratification tools for patients with mC
Beğen
Yorum Yap
Paylaş
